Innovent Biologics Reports Over 50% Revenue Growth in Q1 2026 Driven by Oncology and Biomedicine Portfolio
Innovent Biologics Q1 2026 Product Revenue Announcement ...
Sign in to continue:
Innovent Biologics Q1 2026 Product Revenue Announcement ...
Jiangsu Expressway Announces Proposed RMB500 Million Investm...
China Lesso Group Holdings Limited 2025 Annual Report: Key I...
United Energy Group Limited 2025 Annual Report: Key Highligh...
FWD Group Q1 2026 New Business Report: Detailed Investor Ana...
China Shanshui Cement Group Limited 2025 Annual Report - Inv...
Hilong Holding Limited 2025 Annual Report: Key Highlights an...
Z Fin Limited 2025 Annual Report – Investor Highlights ...
Add New Energy Investment Holdings Group Limited 2025 Annual...
Phancy Group Announces RMB400 Million GPU Server Purchase ...